Seroatlas · Human Serome Atlas

EBLN2

Endogenous Bornavirus-like nucleoprotein 2

Also known as: EBLN2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6P2I7
Gene
EBLN2
Ensembl
ENSG00000255423
Chromosome
3
Canonical length
272 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nuclear bodies

OverviewNCBI Gene

No narrative summary is available for EBLN2 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

272 residues, UniProt reviewed canonical sequence.

>Q6P2I7|EBLN2
     1  MGYFLKLYAY VNSHSLFVWV CDRSYKRSFR PMILNKIKEL SRNQFSTMSH LRKDSQPSSP
    61  GDDAMDRSGL PDLQGRFELS GKNRQYPLDA LEPQPSIGDI KDIKKAAKSM LDPAHKSHFH
   121  PVTPSLVFLC FIFDGLHQAL LSVGVSKRSN TVVGNENEER GTPYASRFKD MPNFIALEKS
   181  SVLRHCCDLL IGIAAGSSDK ICTSSLQVQR RFKAMMASIG RLSHGESADL LISCNAESAI
   241  GWISSRPWVG ELMFTLLFGD FESPLHKLRK SS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against EBLN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.37
Highest tissue expression
15 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 15 nTPM
  • ovary: 3.5 nTPM
  • fallopian tube: 2.6 nTPM
  • lung: 2.6 nTPM
  • salivary gland: 2.6 nTPM
  • retina: 2.5 nTPM

Single-cell type

  • enterocytes: 0.1 nCPM
  • microglia: 0.1 nCPM
  • schwann cells: 0.1 nCPM
  • adipocytes: 0 nCPM
  • adrenal cortex cells: 0 nCPM
  • adrenal medulla cells: 0 nCPM

Immune cell

  • eosinophil: 3.3 nTPM
  • T-reg: 1.9 nTPM
  • naive CD8 T-cell: 1.7 nTPM
  • gdT-cell: 1.6 nTPM
  • neutrophil: 1.5 nTPM
  • memory CD4 T-cell: 1.4 nTPM

Brain region

  • white matter: 12 nTPM
  • choroid plexus: 7.4 nTPM
  • medulla oblongata: 7.4 nTPM
  • basal ganglia: 6.9 nTPM
  • pons: 6.7 nTPM
  • cerebral cortex: 6.6 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD missense Z
-0.85
DepMap mean gene effect
0.1
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

Protein domainsUniProt · Pfam · InterPro

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads EBLN2 as an antibody target. Whether an autoantibody or antibody against EBLN2 could matter depends on whether native EBLN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

EBLN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label EBLN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/EBLN2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...